Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Many of Australia's top brokers have been busy adjusting their financial models and recommendations again. This has led to the release of a number of broker notes this week.

Three ASX shares that brokers have named as buys this week are listed below. Here's why their analysts are feeling bullish on them right now:

A man in his office leans back in his chair with his hands behind his head looking out his window at the city.

Image source: Getty Images

Boss Energy Ltd (ASX: BOE)

According to a note out of Bell Potter, its analysts have retained their buy rating on this uranium producer's shares with a reduced price target of $2.90. This follows the release of guidance for FY 2026. Bell Potter notes that its guidance for production of 1.6Mlbs was well short of its estimate of 1.99Mlbs and also the market's estimate of 1.7Mlbs. However, while this was disappointing, it believes the post-update selloff has created a buying opportunity for investors. It also notes that it takes the view that uranium prices will continue to rise over the coming years. This is good news and would provide margin relief for Boss Energy should its production costs remain elevated. The Boss Energy share price is trading at $1.81 today.

James Hardie Industries plc (ASX: JHX)

A note out of Macquarie reveals that its analysts have upgraded this building materials company's shares to an outperform rating with an improved price target of $46.80. The broker has now included the AZEK acquisition into its model. And while market conditions remain tough, it is feeling upbeat. This is due to the emergence of a better synergy position (or storyline) and the nearing of a cyclical recovery. In respect to synergies, the broker highlights that there are fundamental business model opportunities that leverage James Hardie's strengths that are under-appreciated in the ability to change profitability and cash flow profiles. The James Hardie share price is fetching $42.48 at the time of writing.

Polynovo Ltd (ASX: PNV)

Another note out of Macquarie reveals that its analysts have retained their outperform rating on this medical device company's shares with a trimmed price target of $2.45. This follows the release of a full year update which revealed strong sales growth in FY 2025. Overall, the broker appears pleased with the company's performance and continues to see significant value on offer here for investors even after trimming its valuation to reflect lower earnings per share forecasts. The Polynovo share price is trading at $1.33 on Wednesday afternoon.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and PolyNovo. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended PolyNovo. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Thumbs down Facebook icon over dark screen.
Broker Notes

Why these 5 ASX shares were downgraded by brokers this week

Market analysts explain why they've downgraded these ASX stocks.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: Domino's Pizza, Super Retail, PLS shares

Let's check out some new ratings on ASX shares today.

Read more »

Smiling woman taking a video through a plane window with her phone.
Broker Notes

Qantas or Virgin shares. Which ASX airline has more upside?

Will either share take off soon?

Read more »

A little girl wearing wonky glasses checks out what's happening in the world on a mobile phone.
Broker Notes

Buy, hold, sell: Paladin Energy, Accent, Sigma Healthcare shares

Experts reveal the reasons behind their new ratings.

Read more »

A woman looks excited as she fans out a wad of Aussie $100 notes.
Broker Notes

Macquarie predicts 90% upside and an 8% dividend yield for this ASX share

If the broker is right, this share will pay off nicely.

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

ASX 200 healthcare shares rebound 57% in 5 months. Here's 1 to buy and 1 to sell: experts

It's time to take profits on one share, while the other has more growth left, say these experts.

Read more »

Young man with a laptop in hand watching stocks and trends on a digital chart.
Broker Notes

Buy, hold, sell: Fortescue, Santos, CBA shares

Let's review some new expert ratings and insights on 3 ASX 200 heavyweights.

Read more »

An unhappy man in a suit sits at his desk with his arms crossed staring at his laptop screen as the PointsBet share price falls
Broker Notes

BHP, Westpac, CSL shares: Buy, sell, or hold?

One of these ASX shares is tipped to fall 13%.

Read more »